Part 17/19:
The reliance on foreign suppliers for critical medicines constitutes a national security risk, reminiscent of vulnerabilities exposed during the pandemic. If geopolitical tensions escalate, or if India or China decide to restrict exports, the US could face shortages of antibiotics, anesthetics, or even life-saving treatments.
Furthermore, China’s investments in biotech and its ambitions to lead in innovative pharmaceuticals threaten US leadership in this critical sector. This presents a dual challenge: safeguarding public health and maintaining technological and strategic superiority.